David Burgstahler is the Managing Partner and Chief Executive Officer of Avista Capital Partners. Prior to co-founding Avista Capital Partners in 2005, Mr. Burgstahler was a Partner of DLJ Merchant Banking Partners and Head of Healthcare. Mr. Burgstahler was at DLJ Investment Banking from 1995 to 1997 and DLJMB from 1997 to 2005. Prior to joining DLJ, he worked at McDonnell Douglas (now Boeing) from 1987 to 1990 and Andersen Consulting (now Accenture) from 1991 to 1993.
Mr. Burgstahler received a B.S. in Aerospace Engineering from the University of Kansas and an M.B.A. from Harvard Business School.
Mr. Burgstahler currently serves as a Director of Cosette Pharmaceuticals, RVL Pharmaceuticals (Nasdaq: RVLP), Spear Education, United BioSource Corporation, XIFIN and other private boards. He previously served on the boards of AngioDynamics (Nasdaq: ANGO), Arcadia Consumer Healthcare, Armored AutoGroup, BioReliance, ConvaTec Group, Focus Diagnostics, INC Research Holdings (Nasdaq: INCR), Inform Diagnostics, Lantheus Holdings (Nasdaq: LNTH), MPI Research, Inc., Strategic Partners, Visant, Warner Chilcott (Nasdaq: WCRX) and WideOpenWest (NYSE: WOW).